(Q28270880)

2

0 references

M L Long

3

0 references

D P Ablett

4

0 references

G M Klein

5

0 references

D A DeForge

Canadian Journal of Neurological Sciences

6

0 references

language of work or name

English

0 references

publication date

August 1995

0 references

published in

0 references

volume

22

0 references

page(s)

208-17

0 references

issue

3

0 references

cites work

Effect of intrathecal baclofen on bladder and sphincter function

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Selective functional posterior rhizotomy for treatment of spastic cerebral palsy in children. Review of 50 consecutive cases

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Control of spasticity by implantable continuous flow morphine pump

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Effect of intrathecal baclofen on the monosynaptic reflex in humans: evidence for a postsynaptic action

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Reduction by baclofen of monosynaptic EPSPs in lumbosacral motoneurones of the anaesthetized cat.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Intrathecal baclofen down-regulates GABAB receptors in the rat substantia gelatinosa

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Continuous intrathecal baclofen in spinal cord spasticity. A prospective study

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Efficacy of dorsal longitudinal myelotomy in treating spinal spasticity: a review of 20 cases

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Chronic intrathecal baclofen administration for control of severe spasticity

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Chronic intrathecal baclofen administration in severe spasticity.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Long-term intrathecal baclofen infusion for treatment of spasticity

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Intrathecal baclofen for spasticity of spinal origin: seven years of experience

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Activation of GABAB receptors causes presynaptic inhibition at synapses between muscle spindle afferents and motoneurons in the spinal cord of bullfrogs.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Effects of intrathecal baclofen on voluntary motor control in spastic paresis.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Intrathecal baclofen for severe spinal spasticity

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021

Continuous intrathecal baclofen for severe spasticity

1 reference

https://api.crossref.org/works/10.1017%2FS031716710003986X

7 January 2021